talazoparib in locally advanced or metastatic breast cancer
Published 3 years ago • 257 plays • Length 3:52Download video MP4
Download video MP3
Similar videos
-
1:12
dr. joanne blum on the function of talazoparib in locally advanced and/or metastatic breast cancer
-
2:47
talave: induction talazoparib with parp inhibition in breast cancer
-
2:21
a study of talazoparib in somatic brca1/2 mutant mbc identified by cfdna or tumor tissue genotyping
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
3:52
the phase 3 embraca study of talazoparib in brca-related metastatic breast cancer
-
9:21
dr. litton on activity of talazoparib in advanced brca1/2 breast cancer
-
3:27
tripathy discusses a study of talazoparib in brca-mutated advanced breast cancer
-
2:07
parp inhibitors and the embraca study of talazoparib in brca-related metastatic breast cancer
-
1:26
ribecca: ribociclib, a cdk4/6 inhibitor in er breast cancer
-
2:46
preliminary data on op-1250 palbociclib in advanced/metastatic er /her- breast cancer
-
2:47
embraca: results of talazoparib vs chemotherapy relative to prior ct in patients with advanced b...
-
6:18
talazoparib in patients with advanced breast cancer and germline brca mutation
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
2:59
brocade3: veliparib with carboplatin/paclitaxel in her2-/brca advanced breast cancer
-
3:45
current research into treatments for brca-related breast cancer and the phase 3 embraca trial
-
5:28
capitello-291: capivasertib fulvestrant for ai-resistant hr /her2- advanced breast cancer
-
2:15
parp inhibitors in metastatic breast cancer: where are we now?
-
3:05
exploring the use of olaparib in advanced breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer